If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 15 Similar Profiles
Multiple Sclerosis Medicine & Life Sciences
Interferons Medicine & Life Sciences
Measles virus Medicine & Life Sciences
Subacute Sclerosing Panencephalitis Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Cytokines Medicine & Life Sciences
Measles Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1981 2019

Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis

Yadav, S. K., Soin, D., Ito, K. & Dhib-Jalbut, S., Apr 12 2019, In : Journal of Molecular Medicine. 97, 4, p. 463-472 10 p.

Rutgers, The State University

Research output: Contribution to journalReview article

Multiple Sclerosis
Mouth Diseases
Th2 Cells
Myeloid Cells
Blood-Brain Barrier
11 Citations (Scopus)

Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood

Yadav, S. K., Boppana, S., Ito, N., Mindur, J. E., Mathay, M. T., Patel, A., Dhib-Jalbut, S. & Ito, K., Oct 31 2017, In : Proceedings of the National Academy of Sciences of the United States of America. 114, 44, p. E9318-E9327

Rutgers, The State University

Research output: Contribution to journalArticle

Dysbiosis
Central Nervous System
Multiple Sclerosis
Autoimmunity
Autoimmune Experimental Encephalomyelitis
4 Citations (Scopus)

IL-27: a potential biomarker for responders to glatiramer acetate therapy

Mindur, J. E., Valenzuela, R. M., Yadav, S. K., Boppana, S., Dhib-Jalbut, S. & Ito, K., Mar 15 2017, In : Journal of Neuroimmunology. 304, p. 21-28 8 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Interleukin-27
Biomarkers
Therapeutics
Relapsing-Remitting Multiple Sclerosis
Glatiramer Acetate
51 Citations (Scopus)

Brain health: time matters in multiple sclerosis

Giovannoni, G., Butzkueven, H., Dhib-Jalbut, S., Hobart, J., Kobelt, G., Pepper, G., Sormani, M. P., Thalheim, C., Traboulsee, A. & Vollmer, T., Jun 30 2016, In : Multiple Sclerosis and Related Disorders. 9, p. S5-S48

Rutgers, The State University

Research output: Contribution to journalReview article

Multiple Sclerosis
Health
Brain
Therapeutics
Consensus
54 Citations (Scopus)

Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: A randomised, placebo-controlled, phase 2 trial

Voskuhl, R. R., Wang, H. J., Wu, T. C. J., Sicotte, N. L., Nakamura, K., Kurth, F., Itoh, N., Bardens, J., Bernard, J. T., Corboy, J. R., Cross, A. H., Dhib-Jalbut, S., Ford, C. C., Frohman, E. M., Giesser, B., Jacobs, D., Kasper, L. H., Lynch, S., Parry, G., Racke, M. K. & 7 othersReder, A. T., Rose, J., Wingerchuk, D. M., MacKenzie-Graham, A. J., Arnold, D. L., Tseng, C. H. & Elashoff, R., Jan 1 2016, In : The Lancet Neurology. 15, 1, p. 35-46 12 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Relapsing-Remitting Multiple Sclerosis
Estriol
Placebos
Recurrence
Multiple Sclerosis

Press/Media

At the Board: June 2018

Suhayl Dhib-Jalbut

6/12/18

1 item of media coverage

Press/Media: Press / Media

AT THE BOARD: JUNE 2018

Suhayl Dhib-Jalbut

6/12/18

1 item of media coverage

Press/Media: Press / Media

ACTRIMS 2018: Emerging Pathways, New Therapeutic Targets in MS

Suhayl Dhib-Jalbut

1/29/18

1 item of media coverage

Press/Media: Press / Media

Dementia & Neurogenetics Faculty

Suhayl Dhib-Jalbut

1/27/18

1 item of media coverage

Press/Media: Press / Media